ORIXHA

Orixhas mission is to save the patientss lifes in critical care through liquid ventilation. Orixha is developing the Vent2Cool medical device to almost immediately protect the vital organs, in particular the brain and heart, of patients resuscitated after cardiac arrest and thus significantly reduce mortality and morbidity. Vent2Cool turns the lungs into a heat exchanger with the blood compartment. This makes it possible to induce ultra-rapid therapeutic hypothermia in minutes where current hypothermia solutions take hours to reach the target temperature of 33C

Orixha operates in the Medical equipment manufacturing industry.

Orixha's revenue is 11m - 100m

Orixha has 11 - 50 employees.